Clincosm LogoSign in Get a demo

venous thromboembolic disease

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

'CTR' Ratio With Standard Haemostasis Parameters in Follow-up of

Recruiting
  • Venous Thromboembolic Disease
    • Saint-Mandé, France
      HIA Bégin
    Aug 7, 2023

    Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism Trial (The multifaceted interventions, Routine VTE

    Recruiting
    • Venous Thromboembolic Disease
    • +4 more
    • The multifaceted interventions
    • Routine VTE prophylaxis
    • Beijing, Beijing, China
      China-Japan Friendship Hospital
    Jan 19, 2023

    Venous Thromboembolic Disease Trial in France (Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP))

    Not yet recruiting
    • Venous Thromboembolic Disease
    • Full-dose anticoagulant therapy (AC)
    • Antiplatelet therapy (AP)
    • Amiens, France
    • +27 more
    Jan 13, 2023

    Venous Thromboembolism in Hematologic Malignancy and

    Active, not recruiting
    • Thrombosis, Venous
    • +4 more
      • Toronto, Ontario, Canada
        Federico Carini
      Nov 21, 2022

      D-dimer Combined With Other Thrombus Molecular Markers in Risk

      Not yet recruiting
      • Venous Thromboembolic Disease
      • Venous blood was collected from patients under fasting state to detect the level of thrombus molecular markers
      • Jinan, Shan Dong, China
        The First Affiliated Hospital of Shandong First Medical Universi
      Aug 24, 2022

      Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia Trial in Dijon (treatment "intervention",

      Recruiting
      • Prolonged Anticoagulation
      • +2 more
      • treatment "intervention"
      • +2 more
      • Dijon, France
        Chu Dijon Bourgogne
      Jul 4, 2022

      Clotting Parameters After Medical Abortion

      Completed
      • Abortion Early
      • +7 more
      • Thromboelastometry
      • +4 more
      • Edinburgh, United Kingdom
        Chalmers Centre for Sexual and Reproductive Health
      Apr 19, 2022

      Hemorrhagic Risk in Patients Over 75 Years of Age Taking

      Recruiting
      • Venous Thromboembolic Disease
        • Strasbourg, France
          Service de Gériatrie. Soins de Longue Durée - Hôpitaux Universit
        Nov 25, 2021

        Venous Thromboembolic Disease, Respiratory Disease, Pulmonary Disease Trial in Spain (Fludeoxyglucose 18F)

        Recruiting
        • Venous Thromboembolic Disease
        • +6 more
        • Fludeoxyglucose 18F
        • Badalona, Barcelona, Spain
        • +16 more
        Nov 25, 2021

        Venous Thromboembolic Disease, Pulmonary Embolism, Deep Venous Thrombosis Trial (Bleeding-risk based prophylaxis strategy during

        Not yet recruiting
        • Venous Thromboembolic Disease
        • +2 more
        • Bleeding-risk based prophylaxis strategy during hospitalization and extended pharmacological treatment after discharge
        • Routine VTE prophylaxis in hospital
        • (no location specified)
        Aug 1, 2021

        Anticoagulation Strategies for Acute Venous Thromboembolism in

        Completed
        • Venous Thromboembolic Disease
        • Kidney Failure, Chronic
        • Baltimore, Maryland
          Johns Hopkins University
        Jul 22, 2021

        Predictors of Attempted Inferior Vena Cava Filters Retrieval.

        Completed
        • Venous Thromboembolic Disease
        • Data collection
        • Saint-Étienne, France
          Chu Saint-Etienne
        Apr 13, 2021

        Venous Thromboembolic Disease, Deep Venous Thrombosis, Right Heart Pathology Trial (Data collection only)

        Completed
        • Venous Thromboembolic Disease
        • +3 more
        • Data collection only
        • (no location specified)
        May 29, 2020

        After Edoxaban Versus Vitamin K Antagonists for Acute VTE

        Unknown status
        • Venous Thromboembolic Disease
        • +3 more
        • Observation
        • Amsterdam, Netherlands
          Academisch Medisch Centrum
        Jul 2, 2019

        Venous Thromboembolism in Women During Hormonal Exposure

        Unknown status
        • Venous Thromboembolic Disease
        • Case group
        • Control group
        • Brest, France
          CHRU Brest
        Apr 11, 2019

        Ancillary Study of the REMOTEV Study

        Unknown status
        • Venous Thromboembolic Disease
          • Strasbourg, France
            Service Des Maladies Vasculaires - Hta - Nhc
          Mar 21, 2019

          Venous Thromboembolic Disease, Deep Vein Thrombosis, Pulmonary Embolism Trial in San Diego (5000 Units unfractionated Heparin Q

          Completed
          Has Results
          • Venous Thromboembolic Disease
          • +2 more
          • 5000 Units unfractionated Heparin Q 8 hr
          • 30mg enoxaparin Q12 hr
          • San Diego, California
            Scripps Mercy Hospital
          Jun 7, 2016

          FDG-PET/CT Imaging in Management of Thromboembolic Disorders

          Completed
          • Venous Thromboembolic Disease
            • Odense, Denmark
            • +2 more
            Oct 26, 2014

            Venous Thromboembolic Disease Trial in Strasbourg

            Unknown status
            • Venous Thromboembolic Disease
              • Strasbourg, France
                Service Des Maladies Vasculaires - Hta - Nhc
              Oct 20, 2014

              Pulmonary Embolism, Venous Thromboembolic Disease Trial (Bard Recovery G2 Filter System)

              Completed
              Has Results
              • Pulmonary Embolism
              • Venous Thromboembolic Disease
              • Bard Recovery G2 Filter System
              • (no location specified)
              May 25, 2012

              Atrial Fibrillation, Atrial Flutter, Venous Thromboembolic Disease Trial in United States (ATI-5923, Coumadin (warfarin))

              Unknown status
              • Atrial Fibrillation
              • +4 more
              • Birmingham, Alabama
              • +40 more
              Feb 1, 2010